$NORD 3 SEC Filings

Filed On	Filing
10 Dec 2024	Form 3: Keller Henrik, Director
10 Dec 2024	Form 3: Severin Bach Peter, Director
10 Dec 2024	Form 3: Ac Nordic ApS, 10% owner Holds 3,143,198 shares of Common stock
05 Jun 2024	Form 3: Alteral Therapeutics ApS, 10% owner Holds 12,652,279 shares of Common Stock
08 Sep 2022	Form 3: Oerbekker Henrik, 10% owner Holds 778,618 shares of Common Stock
21 Jul 2022	Form 3: Gk Partners ApS, 10% owner Holds 3,557,239 shares of Common Stock
18 Oct 2021	Form 3: Rouf Henrik, 10% owner Holds 25,570,490 shares of Common Stock
20 Apr 2016	Form 3: Carroll Khristine L, EVP of Commercial Operations Holds 270,309 shares of Common Stock
06 Sep 2013	Form 3: Tauscher Mark R, Director
19 Sep 2012	Form 3: Volpe David Crispino, Chief Financial Officer Holds 153 shares of Common Stock
15 Aug 2007	Form 3: Beck Philip Alan, General manager
26 Apr 2007	Form 3: Reed Andrew Martin, VP of Science and Technology
07 Oct 2005	Form 3: Walters Eric G, VP and CFO
16 Feb 2005	Form 3: Dorsey Jeremiah E, Director
15 Jul 2004	Form 3: Oneill William J Jr, Director
28 Aug 2003	Form 3: Whittaker Douglas E, President Gish Biomedical
28 Aug 2003	Form 3: Taeger Leslie M, CFO Holds 26,844 shares of Common stock
10 Apr 1998	Form 3

Comments